The aim of the current study is to determine the expression of Trx 1, Prx 1 and Prx 2 in squamous cervical carcinoma and their potential roles in predicting chemoresistance among stage IB2 or IIA2 squamous cervical cancer patients treated with neoadjuvant chemotherapy. This evidence concerns the gene PRRX2 and cervical squamous cell carcinoma.